US Broker Ratings

AbbVie Inc. (ABBV) Stock Analysis: A Robust Healthcare Giant with a 112.85% ROE and Strategic Upside

AbbVie Inc. (NYSE: ABBV) continues to solidify its position as a formidable player in the healthcare sector, distinguished by its robust portfolio of biopharmaceutical innovations. Headquartered in North Chicago, Illinois,..

Bio-Techne Corp (TECH) Stock Analysis: Navigating the Biotechnology Sector with a 8.44% Potential Upside

Bio-Techne Corp (NASDAQ: TECH) stands as a formidable player in the biotechnology sector, boasting a robust portfolio of life science reagents, instruments, and services. Headquartered in Minneapolis, Minnesota, this nearly..

IQVIA Holdings, Inc. (IQV) Investor Outlook: Analyzing Potential Upside and Robust Market Position

For investors seeking opportunities within the healthcare sector, IQVIA Holdings, Inc. (IQV) stands out as a compelling choice. With a current market capitalization of $34.77 billion, IQVIA is a prominent..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a Resilient Player in the Healthcare Sector with a 2.52% Upside Potential

Molina Healthcare Inc (NYSE: MOH) stands out as a significant player in the healthcare plans industry, especially known for providing managed care services to individuals and families under Medicaid and..

Genmab A/S (GMAB) Stock Analysis: Exploring a 13.18% Potential Upside in the Biotech Sector

Investors eyeing opportunities in the biotechnology sector would do well to consider Genmab A/S (NASDAQ: GMAB), a Danish company making significant strides with its antibody-based products for cancer treatment. With..

Zoetis Inc. (ZTS) Investor Outlook: 31% Potential Upside and Strong Buy Ratings

Zoetis Inc. (NYSE: ZTS), a leading player in the healthcare sector, particularly in the arena of animal health, presents a compelling investment opportunity with a significant potential upside of 31.08%...

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating Growth and Investor Sentiment in Healthcare

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, continues to capture investor attention with its robust performance metrics and strategic position within the medical care..

Globus Medical, Inc. (GMED) Stock Analysis: Uncovering a 33.60% Potential Upside

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector focusing on medical devices, is capturing investor attention with a notable potential upside of 33.60%. As a leader..

Baxter International Inc. (BAX) Investor Outlook: Analyzing the 21% Potential Upside

Baxter International Inc. (NYSE: BAX) finds itself at a pivotal juncture, presenting a compelling opportunity for investors seeking exposure within the healthcare sector. With a market capitalization of $11.86 billion,..

ICON plc (ICLR) Stock Analysis: Unpacking the 16.97% Potential Upside

Investors with a keen eye on the healthcare sector might find ICON plc (NASDAQ: ICLR) an attractive proposition given its significant potential upside of 16.97%. This Dublin-headquartered clinical research organization..

AptarGroup, Inc. (ATR) Stock Analysis: Strong Buy Ratings and 35.85% Potential Upside

AptarGroup, Inc. (NYSE: ATR) is capturing the attention of investors with its solid position in the healthcare sector, specifically within the medical instruments and supplies industry. As a leading designer..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Powerhouse with Robust Revenue Growth

The Ensign Group, Inc. (NASDAQ: ENSG) stands out as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $10.5 billion,..

Encompass Health Corporation (EHC) Investor Outlook: Strong Buy Ratings and Promising Upside Potential

Encompass Health Corporation (NYSE: EHC) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $12.55 billion, this U.S.-based..

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook with a Promising 77.89% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a pioneering biotechnology firm headquartered in San Rafael, California, is making waves in the healthcare sector with its innovative solutions for rare diseases. The company’s..

Fresenius Medical Care AG (FMS) Stock Analysis: Unveiling a 6.36% Upside in the Healthcare Sector

Fresenius Medical Care AG (NYSE: FMS) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $15.94 billion, this..

Humana Inc. (HUM) Stock Analysis: Navigating a Potential 7.41% Upside in the Healthcare Sector

Investors seeking opportunities within the healthcare sector might find Humana Inc. (NYSE: HUM) an intriguing prospect, especially in light of its potential upside of 7.41%. With a robust market presence..

Labcorp Holdings Inc. (LH) Stock Analysis: A Strong Buy with 4.92% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, specifically in the Diagnostics & Research industry, continues to capture the attention of investors. With a market capitalization..

Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating a 15.86% Potential Upside in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH) stands as a formidable entity within the healthcare sector, operating primarily in the medical distribution industry. Headquartered in Dublin, Ohio, this U.S.-based company has carved..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 20.60% Potential Upside in the Healthcare Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, operates within the diagnostics and research industry, providing crucial health sciences solutions and technologies. Founded in 1937 and headquartered in..

Moderna, Inc. (MRNA) Investor Outlook: Navigating a 70% Potential Upside Amidst Biotechnology Challenges

Moderna, Inc. (NASDAQ: MRNA) has been a biotech behemoth, particularly spotlighted during the COVID-19 pandemic for its mRNA vaccine breakthrough. As the world continues to grapple with new health challenges,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds